Back close

Prognostic Bio-Marker for Multiple Sclerosis and a Subclinical Assessment of Disease Therewith

Publication Type : Patents

Thematic Areas : Nanosciences and Molecular Medicine

Publisher : U.S. Patent

Source : Number TEMP/E-1/22385/2017-CHE. (Patent Filed) (2017)

Campus : Kochi

School : Center for Nanosciences

Center : Amrita Center for Nanosciences and Molecular Medicine Move, Nanosciences

Department : Nanosciences and Molecular Medicine, Nanosciences

Year : 2017

Abstract :

Cite this Research Publication : Krishnakumar N. Menon, Kumaran, S., and Kuma, S., “Prognostic Bio-Marker for Multiple Sclerosis and a Subclinical Assessment of Disease Therewith ”, U.S. Patent TEMP/E-1/22385/2017-CHE. (Patent Filed)2017.

Admissions Apply Now